Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- An approach to longitudinal studies in a community: the Framingham Study.Ann N Y Acad Sci. 1963; 107: 539-556
- Periaortic fat deposition is associated with peripheral arterial disease: the Framingham Heart Study.Circ Cardiovasc Imaging. 2010; 3: 515-519
- Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.Circulation. 2007; 116: 39-48
- Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: the Multi-Ethnic Study of Atherosclerosis (MESA).Circ Cardiovasc Qual Outcomes. 2010; 3: 228-235
- Quantification of coronary artery calcium using ultrafast computed tomography.J Am Coll Cardiol. 1990; 15: 827-832
- Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study).Am J Cardiol. 2008; 102: 1136-1141
- Prevalence and distribution of abdominal aortic calcium by gender and age group in a community-based cohort (from the Framingham Heart Study).Am J Cardiol. 2012; 110: 891-896
- Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort—consequences for progression studies.Eur J Radiol. 2006; 57: 396-402
- Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue.Int J Obes (Lond). 2009; 33: 226-232
- Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography.Int J Obes (Lond). 2007; 31: 500-506
- Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.Am Heart J. 2002; 143: 961-965
- Intermittent claudication. A risk profile from the Framingham Heart Study.Circulation. 1997; 96: 44-49
- The associations between visceral fat and calcified atherosclerosis are stronger in women than men.Atherosclerosis. 2010; 208: 531-536
- The association between abdominal body composition and vascular calcification.Obesity (Silver Spring). 2011; 19: 2418-2424
- Pericardial fat and systemic vascular calcification.(PhD Thesis) San Diego State University, USA2011
- Ectopic fat depots and cardiovascular disease.Circulation. 2011; 124: e837-e841
- “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.Lancet. 2005; 365: 1817-1820
- Adipose tissue and atherosclerosis: exploring the connection.Arterioscler Thromb Vasc Biol. 2007; 27: 996-1003
- The normal limits, subclinical significance, related metabolic derangements and distinct biological effects of body site-specific adiposity in relatively healthy population.PLoS One. 2013; 8: e61997
- Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study.Atherosclerosis. 2010; 210: 656-661
- Peripheral arterial disease.Circulation. 2005; 111: e169-e172
- The role of shear stress in the pathogenesis of atherosclerosis.Lab Invest. 2005; 85: 9-23
- Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation.J Am Coll Cardiol. 2010; 55: 1679-1687
- Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress.Circulation. 2006; 113: 2744-2753
- Laminar shear stress mechanisms by which endothelial cells transduce an atheroprotective force.Arterioscler Thromb Vasc Biol. 1998; 18: 677-685
Funding: The Framingham Heart Study is supported by the National Heart, Lung, and Blood Institute Framingham Heart Study , contract N01-HC-25195 and HHSN268201500001I .
NHLBI’s Disclaimer: The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the U.S. Department of Health and Human Services.
See page 1222 for disclosure information.